You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
The relief of heartburn and other symptoms associated with gastro-oesophageal reflux disease (GORD). Treatment and prevention of relapse in erosive oesophagitis. Treatment of duodenal and gastric ulcer. Combination therapy for the treatment of peptic ulcer disease associated with Helicobacter pylori infection. Treatment of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs (NSAIDs). Prevention of gastric and duodenal ulcers and erosions associated with NSAIDs in patients assessed as being at high risk of gastroduodenal ulcer or complications of gastroduodenal ulcer. Long-term prevention of relapse in gastric and duodenal ulceration in patients proven to be H.pylori negative or in whom eradication is inappropriate (eg. the elderly) or ineffective. Treatment of Zollinger-Ellison syndrome.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Gastro-oesophageal reflux disease (GORD). ,Symptomatic GORD. ,The relief of heartburn and other symptoms associated with GORD.,Erosive oesophagitis. ,The treatment and prevention of relapse.,Peptic ulcers. ,The treatment of duodenal and gastric ulcer.,Combination therapy for the treatment of peptic ulcer disease associated with Helicobacter pylori infection.,The treatment of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs.,The prevention of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs in patients assessed as being at high risk of gastroduodenal ulcer or complications of gastroduodenal ulcer.,Long-term prevention of relapse in gastric and duodenal ulceration, in patients proven to be Helicobacter pylori negative, or in whom eradication is inappropriate, e.g. the elderly, or ineffective.,Zollinger-Ellison syndrome. ,The treatment of Zollinger-Ellison syndrome.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Gastro-oesophageal reflux disease (GORD). ,Symptomatic GORD. ,The relief of heartburn and other symptoms associated with GORD.,Erosive oesophagitis. ,The treatment and prevention of relapse.,Peptic ulcers. ,The treatment of duodenal and gastric ulcer.,Combination therapy for the treatment of peptic ulcer disease associated with Helicobacter pylori infection.,The treatment of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs.,The prevention of gastric and duodenal ulcers and erosions associated with non-steroidal anti-inflammatory drugs in patients assessed as being at high risk of gastroduodenal ulcer or complications of gastroduodenal ulcer.,Long-term prevention of relapse in gastric and duodenal ulceration, in patients proven to be Helicobacter pylori negative, or in whom eradication is inappropriate, e.g. the elderly, or ineffective.,Zollinger-Ellison syndrome. ,The treatment of Zollinger-Ellison syndrome.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
